Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Infection Risks Among Patients With Multiple Sclerosis Tr... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
0
Authors
Gustavo Luna
15 more
Gustavo Luna
•
Peter Alping
13 more
•
Thomas Frisell
Published
October 7, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Neurology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Neurology
Show all topics
DOI
10.1001/jamaneurol.2019.3365
